Immunogenicity, safety, and reactogenicity of the 10-valent pneumococcal non-typeable Hemophilus influenzae protein D conjugate vaccine (PHiD-CV) when co-administered with the DTPw-HBV/Hib vaccine in Indian infants: A single-blind, randomized, controlled study

Human Vaccines and Immunotherapeutics

Volumn 8, Issue 5, 2012, Pages 612-622

  Lalwani, Sanjay ^a   Chatterjee, Sukanta ^b   Chhatwal, Jugesh ^c   Verghese, Valsan P ^d   Mehta, Shailesh ^e   Shafi, Fakrudeen ^e   Borys, Dorota ^f   Moreira, Marta ^f   Schuerman, Lode ^f  

^a Bharati Vidyapeeth's Medical College   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

^c CHRISTIAN MEDICAL COLLEGE   (India)

^d CHRISTIAN MEDICAL COLLEGE   (India)

^e GlaxoSmithKline Pharmaceuticals Ltd   (India)

^f GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

Co administration; Conjugate vaccine; Immunogenicity; India; Infant; Safety

Indexed keywords

BACTERIUM ANTIBODY; DIPHTHERIA ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS HEPATITIS B VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B ANTIBODY; NON TYPEABLE HAEMOPHILUS INFLUENZAE PROTEIN D ANTIBODY; PNEUMOCOCCUS VACCINE; TETANUS ANTIBODY; TRITANRIX HEPB HIB; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; APPETITE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; COUGHING; CROSS REACTION; DIPHTHERIA; DROWSINESS; DRUG FEVER; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; GEOMETRIC MEAN ANTIBODY CONCENTRATION; HAEMOPHILUS INFECTION; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOGENICITY; IMMUNOLOGICAL PARAMETERS; IMMUNOREACTIVITY; INDIAN; INFANT; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE SWELLING; IRRITABILITY; MALE; MULTICENTER STUDY; NORMAL HUMAN; OPSONOPHAGOCYTIC ACTIVITY TITER; PERTUSSIS; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; REACTOGENICITY; RHINITIS; SEROTYPE; SIDE EFFECT; SINGLE BLIND PROCEDURE; TETANUS; VACCINATION;

ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BACTERIAL CAPSULES; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DRUG TOXICITY; FEMALE; HAEMOPHILUS VACCINES; HEPATITIS B VACCINES; HUMANS; INDIA; INFANT; MALE; OPSONIN PROTEINS; PHAGOCYTOSIS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SINGLE-BLIND METHOD; VACCINATION; VACCINES, COMBINED;

EID: 84863684443     PISSN: None     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.19287     Document Type: Article

References (53)

1. O'Brien KL, Wolfson LJ, Watt JP, Henkle E, Deloria-Knoll M, McCall N, et al. Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates. Lancet 2009; 374:893-902; PMID: 19748398; DOI: 10.1016/S0140-6736(09)61204-6.
2. Lin TY, Shah NK, Brooks D, Garcia CS. Summary of invasive pneumococcal disease burden among children in the Asia-Pacific region. Vaccine 2010; 28:7589-605; PMID: 20674872; DOI: 10.1016/j.vaccine.2010.07.053.
3. Shah AS, Nisarga R, Ravi Kumar KL, Hubler R, Herrera G, Kilgore PE. Establishment of population-based surveillance for invasive pneumococcal disease in Bangalore, India. Indian J Med Sci 2009; 63:498-507; PMID: 20075551; DOI: 10.4103/0019-5359.58879.
4. Klugman K, Tam JS. Pneumococcal conjugate vaccine in Asia and the Pacific: Conference report. Vaccine 2001; 19:4579-87; PMID: 11729814; DOI: 10.1016/S0264-410X(01)00256-0.
5. Berkley JA, Lowe BS, Mwangi I, Williams T, Bauni E, Mwarumba S, et al. Bacteremia among children admitted to a rural hospital in Kenya. N Engl J Med 2005; 352:39-47; PMID: 15635111; DOI: 10.1056/NEJMoa040275.
6. Brent AJ, Ahmed I, Ndiritu M, Lewa P, Ngetsa C, Lowe B, et al. Incidence of clinically significant bacteraemia in children who present to hospital in Kenya: community-based observational study. Lancet 2006; 367:482-8; PMID: 16473125; DOI: 10.1016/S0140-6736(06)68180-4.
7. Sigaúque B, Roca A, Mandomando I, Morais L, Quintó L, Sacarlal J, et al. Community-acquired bacteremia among children admitted to a rural hospital in Mozambique. Pediatr Infect Dis J 2009; 28:108-13; PMID: 19131902; DOI: 10.1097/INF.0b013e318187a87d.
8. Brooks WA, Breiman RF, Goswami D, Hossain A, Alam K, Saha SK, et al. Invasive pneumococcal disease burden and implications for vaccine policy in urban Bangladesh. Am J Trop Med Hyg 2007; 77:795-801; PMID: 17984328.
9. Arifeen SE, Saha SK, Rahman S, Rahman KM, Rahman SM, Bari S, et al. Invasive pneumococcal disease among children in rural Bangladesh: results from a population-based surveillance. Clin Infect Dis 2009; 48:S103-13; PMID: 19191605; DOI: 10.1086/596543.
10. Park IH, Pritchard DG, Cartee R, Brandao A, Brandileone MC, Nahm MH. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae.. J Clin Microbiol 2007; 45:1225-33; PMID: 17267625; DOI: 10.1128/JCM.02199-06.
11. GAVI's PneumoADIP. Pneumococcal Regional Serotype Distribution for Pneumococcal AMC TPP. Department of International Health Johns Hopkins Bloomberg School of Public Health. 30-11-2008; 1-36.
12. Leibovitz E, Jacobs MR, Dagan R. Haemophilus influenzae: a significant pathogen in acute otitis media. Pediatr Infect Dis J 2004; 23:1142-52; PMID: 15626953.
13. Bluestone CD. Clinical course, complications and sequelae of acute otitis media. Pediatr Infect Dis J 2000; 19:S37-46; PMID: 10821471; DOI: 10.1097/00006454-200005001-00007.
14. Hausdorff WP, Yothers G, Dagan R, Kilpi T, Pelton SI, Cohen R, et al. Multinational study of pneumococcal serotypes causing acute otitis media in children. Pediatr Infect Dis J 2002; 21:1008-16; PMID: 12442021; DOI: 10.1097/00006454-200211000-00007.
15. Cherian T, Bhattacharji S, Brahmadathan KN, Lalitha MK, Raghupathy P, Steinhoff MC. Persistent rhinorrhoea in rural Indian children: prevalence and consequences. J Trop Pediatr 2000; 46:365-7; PMID: 11191150; DOI: 10.1093/tropej/46.6.365.
16. Adam D. Global antibiotic resistance in Streptococcus pneumoniae.. J Antimicrob Chemother 2002; 50:1-5; PMID: 12077153; DOI: 10.1093/jac/dkf801.
17. Pneumococcal conjugate vaccine for childhood immunization - WHO position paper. Wkly Epidemiol Rec 2007; 82:93-104; PMID: 17380597.
18. Jain A, Kumar P, Awasthi S. High nasopharyngeal carriage of drug resistant Streptococcus pneumoniae and Haemophilus influenzae in North Indian schoolchildren. Trop Med Int Health 2005; 10:234-9; PMID: 15730507; DOI: 10.1111/j.1365-3156.2004.01379.x.
19. Prymula R, Peeters P, Chrobok V, Kriz P, Novakova E, Kaliskova E, et al. Pneumococcal capsular polysaccharides conjugated to protein D for prevention of acute otitis media caused by both Streptococcus pneumoniae and non-typable Haemophilus influenzae: a randomised double-blind efficacy study. Lancet 2006; 367:740-8; PMID: 16517274; DOI: 10.1016/S0140-6736(06)68304-9.
20. Chevallier B, Vesikari T, Brzostek J, Knuf M, Bermal N, Aristegui J, et al. Safety and reactogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with routine childhood vaccines. Pediatr Infect Dis J 2009; 28:S109-18; PMID: 19325447; DOI: 10.1097/INF.0b013e318199f62d.
21. Bermal N, Szenborn L, Chrobot A, Alberto E, Lommel P, Gatchalian S, et al. The 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) coadministered with DTPw-HBV/Hib and poliovirus vaccines: assessment of immunogenicity. Pediatr Infect Dis J 2009; 28:S89-96; PMID: 19325451; DOI: 10.1097/INF.0b013e318199f901.
22. Vesikari T, Wysocki J, Chevallier B, Karvonen A, Czajka H, Arsène J-P, et al. Immunogenicity of the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) compared to the licensed 7vCRM vaccine. Pediatr Infect Dis J 2009; 28:S66-76; PMID: 19325449; DOI: 10.1097/INF.0b013e318199f8ef.
23. Wysocki J, Tejedor JC, Grunert D, Konior R, Garcia-Sicilia J, Knuf M, et al. Immunogenicity of the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) when coadministered with different neisseria meningitidis serogroup C conjugate vaccines. Pediatr Infect Dis J 2009; 28:S77-88; PMID: 19325450; DOI: 10.1097/INF.0b013e318199f609.
24. Knuf M, Szenborn L, Moro M, Petit C, Bermal N, Bernard L, et al. Immunogenicity of routinely used childhood vaccines when coadministered with the 10-valent pneumococcal non-typeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV). Pediatr Infect Dis J 2009; 28:S97-108; PMID: 19325452; DOI: 10.1097/INF.0b013e318199f61b.
25. Pertussis vaccines - WHO position paper. Wkly Epidemiol Rec 2005; 80:31-9; PMID: 15717398.
26. Dicko A, Odusanya OO, Diallo AI, Santara G, Barry A, Dolo A, et al. Primary vaccination with the 10-valent pneumococcal nontypeable Haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in infants in Mali and Nigeria: a randomized controlled trial. BMC Public Health 2011; 11:882; PMID: 22112189; DOI: 10.1186/1471-2458-11-882.
27. Puumalainen T, Dagan R, Wuorimaa T, Zeta-Capeding R, Lucero M, Ollgren J, et al. Greater antibody responses to an eleven valent mixed carrier diphtheria- or tetanus-conjugated pneumococcal vaccine in Filipino than in Finnish or Israeli infants. Pediatr Infect Dis J 2003; 22:141-9; PMID: 12586978; DOI: 10.1097/01.inf.0000050459.74134.d5.
28. Dagan R, Givon-Lavi N, Greenberg D, Fritzell B, Siegrist CA. Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy. J Infect Dis 2010; 201:1570-9; PMID: 20384496; DOI: 10.1086/652006.
29. Rodenburg GD, van Gils EJ, Veenhoven RH, Bogaert D, van den Dobbelsteen GP, Berbers GA, et al. Lower immunoglobulin G antibody responses to pneumococcal conjugate vaccination at the age of 2 years after previous nasopharyngeal carriage of Streptococcus pneumoniae.. J Pediatr 2011; 159:965-70, e1; PMID: 21813135; DOI: 10.1016/j.jpeds.2011.06.011.
30. Madhi SA, Violari A, Klugman KP, Lin G, McIntyre JA, von Gottberg A, et al. Inferior quantitative and qualitative immune responses to pneumococcal conjugate vaccine in infants with nasopharyngeal colonization by Streptococcus pneumoniae during the primary series of immunization. Vaccine 2011; 29:6994-7001; PMID: 21787822; DOI: 10.1016/j.vaccine.2011.07.035.
31. Väkeväinen M, Soininen A, Lucero M, Nohynek H, Auranen K, Mäkelä PH, et al. Serotype-specific hyporesponsiveness to pneumococcal conjugate vaccine in infants carrying pneumococcus at the time of vaccination. J Pediatr 2010; 157:778-83, e1; PMID: 20547399; DOI: 10.1016/j.jpeds.2010.04. 071.
32. Obaro SK, Steinhoff MC, Shahid N, Siber G. Serum, breast milk, and infant antibody after maternal immunisation with pneumococcal vaccine. Lancet 1996; 347:192-3; PMID: 8544562; DOI: 10.1016/S0140-6736(96)90376-1.
33. Levine OS, Cherian T. Pneumococcal vaccination for Indian children. Indian Pediatr 2007; 44:491-6; PMID: 17684301.
34. Kilpi T, Ahman H, Jokinen J, Lankinen KS, Palmu A, Savolainen H, et al. Protective efficacy of a second pneumococcal conjugate vaccine against pneumococcal acute otitis media in infants and children: randomized, controlled trial of a 7-valent pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine in 1666 children. Clin Infect Dis 2003; 37:1155-64; PMID: 14557958; DOI: 10.1086/378744.
35. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 2001; 344:403-9; PMID: 11172176; DOI: 10.1056/NEJM200102083440602.
36. Black S, Shinefield H, Fireman B, Lewis E, Ray P, Hansen JR, et al. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J 2000; 19:187-95; PMID: 10749457; DOI: 10.1097/00006454-200003000-00003.
37. Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, et al. Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.. N Engl J Med 2006; 354:1455-63; PMID: 16598044; DOI: 10.1056/NEJMoa051642.
38. Knuf M, Habermehl P, Cimino C, Petersen G, Schmitt HJ. Immunogenicity, reactogenicity and safety of a 7-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a DTPa-HBV-IPV/Hib combination vaccine in healthy infants. Vaccine 2006; 24:4727-36; PMID: 16616973; DOI: 10.1016/j.vaccine.2006. 03.032.
39. Olivier C, Belohradsky BH, Stojanov S, Bonnet E, Petersen G, Liese JG. Immunogenicity, reactogenicity, and safety of a seven-valent pneumococcal conjugate vaccine (PCV7) concurrently administered with a fully liquid DTPa-IPV-HBV-Hib combination vaccine in healthy infants. Vaccine 2008; 26:3142-52; PMID: 18502545; DOI: 10.1016/j.vaccine.2007.11.096.
40. Schmitt HJ, Faber J, Lorenz I, Schmöle-Thoma B, Ahlers N. The safety, reactogenicity and immunogenicity of a 7-valent pneumococcal conjugate vaccine (7VPnC) concurrently administered with a combination DTaP-IPV-Hib vaccine. Vaccine 2003; 21:3653-62; PMID: 12922095; DOI: 10.1016/S0264-410X(03) 00389-X.
41. Tichmann-Schumann I, Soemantri P, Behre U, Disselhoff J, Mahler H, Maechler G, et al. Immunogenicity and reactogenicity of four doses of diphtheria-tetanus-three-component acellular pertussis-hepatitis B-inactivated polio virus-Haemophilus influenzae type b vaccine coadministered with 7-valent pneumococcal conjugate Vaccine. Pediatr Infect Dis J 2005; 24:70-7; PMID: 15665713; DOI: 10.1097/01.inf.0000148923.46453.48.
42. Lagos R, Hoffenbach A, Scemama M, Dupuy M, Schodel F, Hessel L, et al. Lot-to-lot consistency of a combined hexavalent diptheria-tetanus-acellular- pertussis, hepatitis B, Inactivated polio and haemophilus B conjugate vaccine, administered to healthy chilean infants at two, four and six months of age. Hum Vaccin 2005; 1:112-7; PMID: 17012870; DOI: 10.4161/hv.1.3.1848.
43. Prymula R, Plisek S. Clinical experience with DTPw-HBV and DTPw-HBV/Hib combination vaccines. Expert Opin Biol Ther 2008; 8:503-13; PMID: 18352853; DOI: 10.1517/14712598.8.4.503.
44. Concepcion NF, Frasch CE. Pneumococcal type 22f polysaccharide absorption improves the specificity of a pneumococcalpolysaccharide enzyme-linked immunosorbent assay. Clin Diagn Lab Immunol 2001; 8:266-72; PMID: 11238206.
45. Poolman JT, Frasch CE, Käyhty H, Lestrate P, Madhi SA, Henckaerts I. Evaluation of pneumococcal polysaccharide immunoassays using a 22F adsorption step with serum samples from infants vaccinated with conjugate vaccines. Clin Vaccine Immunol 2010; 17:134-42; PMID: 19889940; DOI: 10.1128/CVI.00289-09.
46. Henckaerts I, Durant N, De Grave D, Schuerman L, Poolman J. Validation of a routine opsonophagocytosis assay to predict invasive pneumococcal disease efficacy of conjugate vaccine in children. Vaccine 2007; 25:2518-27; PMID: 17034907; DOI: 10.1016/j.vaccine.2006.09.029.
47. Romero-Steiner S, Frasch CE, Carlone G, Fleck RA, Goldblatt D, Nahm MH. Use of opsonophagocytosis for serological evaluation of pneumococcal vaccines. Clin Vaccine Immunol 2006; 13:165-9; PMID: 16467321; DOI: 10.1128/CVI.13.2.165- 169.2006.
48. Rose CE, Romero-Steiner S, Burton RL, Carlone GM, Goldblatt D, Nahm MH, et al. Multilaboratory comparison of Streptococcus pneumoniae opsonophagocytic killing assays and their level of agreement for the determination of functional antibody activity in human reference sera. Clin Vaccine Immunol 2011; 18:135-42; PMID: 21084458; DOI: 10.1128/CVI.00370-10.
49. Camargo ME, Silveira L, Furuta JA, Oliveira EP, Germek OA. Immunoenzymatic assay of anti-diphtheric toxin antibodies in human serum. J Clin Microbiol 1984; 20:772-4; PMID: 6386879.
50. Melville-Smith ME, Seagroatt VA, Watkins JT. A comparison of enzyme-linked immunosorbent assay (ELISA) with the toxin neutralization test in mice as a method for the estimation of tetanus antitoxin in human sera. J Biol Stand 1983; 11:137-44; PMID: 6345548; DOI: 10.1016/S0092-1157(83)80038-9.
51. Eskola J, Ward J, Dagan R, Goldblatt D, Zepp F, Siegrist CA. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus- pertussis containing acellular pertussis. Lancet 1999; 354:2063-8; PMID: 10636384; DOI: 10.1016/S0140-6736(99)04377-9.
52. Hepatitis B virus: a comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination: recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR United States 1991; 40:1-25.
53. Progress in the control of viral hepatitis: memorandum from a WHO meeting. Bull World Health Organ 1988; 66:443-55; PMID: 2971466.